Nationwide survey of anti-tuberculosis drug resistance in Mongolia-Reference-Cited by-同舟云学术

Nationwide survey of anti-tuberculosis drug resistance in Mongolia

Published:2011-09-01 Issue:9 Volume:15 Page:1201-1205
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Buyankhishig B.¹,Naranbat N.¹,Mitarai S.²,Rieder H. L.³

Affiliation:

1. National Center for Communicable Diseases, Ulaanbaatar, Mongolia

2. Research Institute for Tuberculosis, Tokyo, Japan

3. International Union Against Tuberculosis and Lung Disease, Paris, France; Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis;Infectious Diseases of Poverty;2023-05-25

2. Transborder molecular analysis of drug‐resistant tuberculosis in Mongolia and Eastern Siberia, Russia;Transboundary and Emerging Diseases;2022-03-30

3. Molecular epidemiology of multidrug resistant tuberculosis in Mongolia and Eastern Siberia: two independent dissemination processes for dominant strains;Russian Journal of Infection and Immunity;2021-03-24

4. Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis;BMJ Global Health;2020-10

5. Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2020-02